Recombinant human erythropoietin therapy for autologous blood donation in rheumatoid arthritis patients undergoing total hip or knee arthroplasty

被引：0
|
作者：
Matsuda, S [1 ]
Kondo, M [1 ]
Mashima, T [1 ]
Hoshino, S [1 ]
Shinohara, N [1 ]
Sumida, S [1 ]
机构：
[1] Kyushu Univ Hosp, Dept Orthoped Surg, Higashi Ku, Fukuoka 8128582, Japan
来源：
ORTHOPEDICS | 2001年 / 24卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R826.8 [整形外科学]; R782.2 [口腔颌面部整形外科学]; R726.2 [小儿整形外科学]; R62 [整形外科学（修复外科学）];
学科分类号：
摘要：
The effect of recombinant human erythropoietin on autologous blood donation was investigated in 73 rheumatoid arthritis patients who underwent hip or knee arthroplasty. Autologous blood donation of 400 mL was successful with recombinant human erythropoietin (12,000 U per week), and no homologous blood was required. The mean period of blood collection was 33.8 days. Mean hemoglobin levels were 9.7 g/dL before treatment, 10.7 g/dL before surgery, and 10.2 g/dL after surgery. This study confirmed recombinant human erythropoietin is effective for enabling preoperative blood donation in rheumatoid arthritis patients.
引用
收藏
页码：41 / 44
页数：4
相关论文
共 50 条
  • [1] Recombinant human erythropoietin therapy for autologous blood donation in rheumatoid arthritis patients undergoing total hip or knee arthroplasty - Editorial discussion
    Matsuda
    ORTHOPEDICS, 2001, 24 (01) : 44 - 44
  • [2] Erythropoietin for autologous blood donation in total hip arthroplasty patients
    Aksoy M.C.
    Tokgozoglu A.M.
    Archives of Orthopaedic and Trauma Surgery, 2001, 121 (3) : 162 - 165
  • [3] The effects of recombinant human erythropoietin on autologous blood donation in rheumatoid arthritis patients with anaemia
    Matsui, H
    Shiraishi, N
    Yasuda, T
    Nezuka, T
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 1999, 17 (01) : 69 - 74
  • [4] A restrictive use of both autologous donation and recombinant human erythropoietin is an efficient policy for primary total hip or knee arthroplasty
    Couvret, C
    Laffon, M
    Baud, A
    Payen, V
    Burdin, P
    Fusciardi, J
    ANESTHESIA AND ANALGESIA, 2004, 99 (01): : 262 - 271
  • [5] Autologous blood donation and subsequent blood use in patients undergoing total knee arthroplasty
    Bern, M. M.
    Bierbaum, B. E.
    Katz, J. N.
    Losina, E.
    TRANSFUSION MEDICINE, 2006, 16 (05) : 313 - 319
  • [6] Erythropoietin for autologous blood donation in fetal hip arthroplasty patients
    Aksoy, MC
    Tokgozoglu, AM
    ARCHIVES OF ORTHOPAEDIC AND TRAUMA SURGERY, 2001, 121 (03) : 162 - 165
  • [7] RACIAL DISPARITIES IN OUTCOMES FOR PATIENTS WITH RHEUMATOID ARTHRITIS UNDERGOING TOTAL KNEE OR TOTAL HIP ARTHROPLASTY
    Hirsch, Julianna
    Mehta, Bella
    Finik, Jackie
    Mirza, Serene
    Figgie, Mark
    Brantner, Collin
    Navarro-Millan, Iris
    Goodman, Susan
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 1583 - 1583
  • [8] Autologous blood donation with recombinant human erythropoietin in anemic patients
    Kiyama, H
    Ohshima, N
    Imazeki, T
    Yamada, T
    ANNALS OF THORACIC SURGERY, 1999, 68 (05): : 1652 - 1656
  • [9] RECOMBINANT HUMAN ERYTHROPOIETIN AND AUTOLOGOUS BLOOD DONATION
    LEVINE, EA
    ROSEN, AL
    GOULD, SA
    SEHGAL, LR
    EGRIE, JC
    BROWNE, JK
    SEHGAL, HL
    MOSS, GS
    SURGERY, 1988, 104 (02) : 365 - 369
  • [10] USE OF RECOMBINANT-HUMAN-ERYTHROPOIETIN TO ASSIST AUTOLOGOUS BLOOD DONATION BY ANEMIC RHEUMATOID-ARTHRITIS PATIENTS UNDERGOING MAJOR ORTHOPEDIC-SURGERY
    MERCURIALI, F
    GUALTIERI, G
    SINIGAGLIA, L
    INGHILLERI, G
    BIFFI, E
    VINCI, A
    COLOTTI, MT
    BAROSI, G
    DELILIERS, GL
    TRANSFUSION, 1994, 34 (06) : 501 - 506
12345